Elementis Share Discussion Threads

[toffeeman] 16/6/2022 10:14

Has been for a few years now

[gardenarc] 15/6/2022 18:33

Take over target????.

[my retirement fund] 28/4/2022 13:39

Tipped by Jefferies today

[strollingmolby] 26/4/2022 08:15

That's a solid trading update, in spite of the headwinds. The possible sale of the Chromium business introduces some risk as to how much it might be worth to bidders. In 2021 Chromium represented 19% of sales yet only 11% of operating profit, so no wonder the BoD wishes to focus on Coatings and Personal Care, and to a lesser extent, Talc, which had a tough quarter also.

[qs99] 18/3/2022 08:05

Should IMO be heading back to previous levels, otherwise IMO it will be seen as a target by some..DYOR

[qs99] 16/3/2022 10:14

Nice to see continued rise and glad I topped up...DYOR

[qs99] 14/3/2022 09:37

THanks and interesting view after 17% revenue increase last year and "strong new business" statement, reduction in net debt to 401m and ND/EBITDA down to 2.6X CEO statement below and don't forget it was subject to an opportunistic bid recently.... DYOR, but not sure why this should be a sell given the debt improvements being made and statement below? "In 2021 our financial performance was much improved, benefitting from the combination of focused strategy execution and improved industrial demand. In an environment of continued supply chain challenges and accelerating inflation, the Group has demonstrated its resilience and the importance of our continued efficiency focus and targeted pricing actions. We have made an encouraging start to 2022 and expect to deliver an improved financial performance. Continued implementation of our strategy will enable the delivery of $50m of new business opportunities, the launch of 20 new products and progress towards an additional $10m of cost savings by 2023. The fundamentals of our business remain strong. We have a talented team and high quality assets with enduring competitive advantages. I am confident that the implementation of our Innovation, Growth and Efficiency strategy, in combination with our self-help actions, positions us well to deliver our medium term financial objectives and generate significant shareholder value"

[wad collector] 12/3/2022 09:22

Our advisory broker sold at 126 last month and I see down as a Sell in IC today FWIW, sees little upside in earnings and a big debt to service.

[qs99] 04/3/2022 12:37

Looks a mad price drop, did I miss a profit warning somewhere? DYOR

[essentialinvestor] 11/2/2022 18:17

Added a small yesterday.

[toffeeman] 27/1/2022 09:08

Can't see why else we are up in a very down market

[qs99] 27/1/2022 08:57

Would love that to be the case toffeeman!

[toffeeman] 26/1/2022 19:31

Another bid coming?

[qs99] 26/1/2022 14:49

graph beginning to look v. tasty IMO....DYOR

[my retirement fund] 18/1/2022 13:53

position taken here for me

[commander77] 18/1/2022 12:34

toffeeman, be careful you will upset luckyman ?

[toffeeman] 18/1/2022 11:51

I'd be happy with £3

[qs99] 18/1/2022 11:14

v quiet board! wonder if this will see M&A being revisited, last conditional offer was c.£1.60, rejected out of hand before, but with decent trading and debt reduction in place, ahead of economic recoveries, could we see a £2 bid? DYOR

[wardy007] 18/11/2021 08:46

Strong seminar from the company yesterday on innovation. A replay is available on their website I believe ….worth taking a look at……supports the comments from R&M

[simon gordon] 14/11/2021 09:47

R&M Recovery Fund - 31/10/21: We continue to build a position in Elementis, a specialty chemicals producer focused on the coatings, personal care and talc markets. Its potential to deliver improved profit margins is supported by leading positions in niche markets which have recovery potential following covid-19 disruption. Hard to replicate asset bases (chromium, hectorite and talc mines) and, above all, IP (intellectual property) in formulations underpin the quality of its business franchises. Elementis products are typically only a small part of customers’ overall cost (3-5%) but play a critical role and are therefore follow value-based (rather than commodity) pricing structures, another way of saying it has strong pricing power. There are sustainability tailwinds for its products, such as hectorite clay replacing synthetics, which we believe are genuinely incremental and overall, the faster growth in value-add products is shifting margin potential upwards. Share price weakness, which we associated with general investor concerns around the macro outlook rather than anything stock specific, has given us the opportunity to buy at ~12x normalised free cash flow. We see this as an attractive discount to fair value whether you look at the group as a whole or broken up into the sum of its parts.

[epistrophy] 28/10/2021 12:40

Maintaining guidance in a tough environment - seems positive to me.

[essentialinvestor] 11/10/2021 14:10

Input cost possibly impacting margins would guess is what the market may be focussing on. High operational gearing as well as a result of net debt. See what they have to say shortly on the update.